ArticleFrontiers in neurology2025
Analysis and comparison of the trends in the burden of migraine in China and globally from 1990 to 2021, with a forecast to 2031.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cumulative adverse childhood experiences increase migraine risk in later life in China: evidence from CHARLS with mediation and Mendelian randomization.The journal of headache and pain · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine is a prevalent neurological disorder in China and globally, imposing significant burdens on individuals and societies. The goal of this study was to characterize age- and sex-specific temporal patterns in migraine burden in China and worldwide from 1990 to 2021, focusing on incidence, prevalence, and disability-adjusted life years (DALYs). Methods: This retrospective population-based study utilized data from the Global Burden of Disease (GBD) Study in 2021 to analyze the characteristics of migraine burden in China and globally. The study focused on changes in incidence, prevalence, and DALYs. Joinpoint analysis was employed to calculate the average annual percentage change (AAPC) and the corresponding 95% confidence interval (95% CI) to assess trends in the burden of migraine. The Autoregressive Integrated Moving Average (ARIMA) model was utilized to predict the migraine burden for the next decade. Results: The worldwide age-standardized incidence rate (ASIR) of migraine rose from 1136.90/100,000 to 1153.20/100,000 between 1990 and 2021, whereas the ASIR in China grew from 917.35/100,000 to 975.61/100,000. Globally, the age-standardized prevalence rate (ASPR) rose from 14027.65/100,000 to 14246.55/100,000, while in China, it rose from 10948.52/100,000 to 11777.51/100,000. Female rates consistently exceed male rates across all age groups. Migraine incidence peaked in the 10-14 age group, while the prevalence and disability-adjusted life years (DALYs) peaked in the 30-34 age group for both females and males in 2021. The ARIMA model forecasts an upward trend in the ASIR and age-standardized DALYs rate (ASDR) for males in China over the next decade. Furthermore, the ASIR, ASDR, and ASPR for males globally, along with the ASIR and ASPR for females globally, are also anticipated to increase by 2031. Conclusion: Our findings indicate a rising burden of migraine in China and globally. Females are more susceptible to migraine in all age groups. The burden of migraine is age-related, with adolescents and youths facing a higher risk. More research is needed to determine the risk factors and illness patterns linked to migraine to facilitate early diagnosis, prompt therapies, and lessen patient burden, especially for females and adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.